Search results
Added:
9 months ago
Source:
Radcliffe Vascular
The use of paclitaxel-coated devices for infrainguinal endovascular revascularisation does not reduce the rate of major amputation or all-cause mortality in patients with chronic limb-threatening ischaemia (CLTI), according to findings from a large registry-based trial in Sweden.¹ Peripheral artery disease (PAD) is a significant global health issue, and for patients with its most severe form,…
View more
Post-revascularisation de Winter Pattern
Added:
6 months ago
Case Report
Added:
6 months ago
Source:
Radcliffe Cardiology
A study has found that while the severity of ischaemia correlates poorly with daily angina symptoms in patients with stable coronary artery disease (CAD), the development of coronary collateral circulation is associated with both the ischaemic burden and reduced intensity of ischaemic chest pain.¹ This may help explain the often-observed disconnect between stenosis severity and patient-reported…
View more
Added:
9 months ago
Source:
Transcatheter Academy
The use of paclitaxel-coated devices did not reduce the rate of major amputations or death in patients with chronic limb-threatening ischaemia (CLTI) undergoing infrainguinal endovascular revascularisation, according to the results of a large registry-based trial.¹ While drug-coated devices are commonly used in peripheral interventions, their effect on amputation risk has been uncertain.²The…
View more
Added:
3 weeks ago
EuroPCR 2026 – Dr Brian Bergmark (Brigham and Women's Hospital, Boston, MA, US) joins us to discuss findings from the VESALIUS-CV trial, examining the effect of evolocumab in patients who have undergone coronary stenting but have no prior myocardial infarction or stroke.VESALIUS-CV is a double-blind, randomised, placebo-controlled, multicentre phase 3 trial enrolling 12,301 high-cardiovascular…
View more
ESC 25: SWEDEPAD 1 and 2
Added:
9 months ago
Video
Added:
9 months ago
Source:
Transcatheter Academy
The long-term durability of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease has been a subject of recent debate. New 3-year follow-up data from the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) trial show that the clinical benefits of a physiology-guided complete revascularization strategy are sustained over time…
View more
Arnaud Bisson
Author
Added:
1 year ago
LINC 2025 - Three-year outcomes of drug-coated balloon (DCB) treatment for femoropopliteal (FP) chronic total occlusive (CTO) lesions show low patency rates in patents with multiple independent risk factors for patency loss. However, patients without risk factors achieved acceptable patency rates and clinical outcomes of freedom from clinically driven target lesion revascularization, reoclussion…
View more
Added:
1 year ago